AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
PepGen Inc.
Video analysis: PEPG
All videosNo video analysis for this stock yet. Request one from our team.
News: PEPG
ADAR1 Capital Management LLC Acquires New Shares in PepGen, Inc. $PEPG
ADAR1 Capital Management LLC acquired a new position in PepGen, Inc. (NASDAQ: PEPG) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 2,591,085 shares of the company's stock, valued at approximately $4,664,000. ADAR1 Capital Management LLC owned approximately 3.74% of PepGen as of
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
[url="]PepGen Inc.[/url] (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of tran
PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights.
PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review
BOSTON--(BUSINESS WIRE)---- $PEPG #DM1--PepGen to Advance PGN-EDODM1 into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review.
